about
A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trial.Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial.PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.Effect of vitamin A supplementation in women of reproductive age on cause-specific early and late infant mortality in rural Ghana: ObaapaVitA double-blind, cluster-randomised, placebo-controlled trial.Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testingHealth-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer.Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer.Effect of vitamin A supplementation on cause-specific mortality in women of reproductive age in Ghana: a secondary analysis from the ObaapaVitA trial.The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial.Evidence-based guidelines and decision support services: A discussion and evaluation in triple assessment of suspected breast cancer.Cancer risks in populations living near landfill sites in Great Britain.Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.Vaccination timing of low-birth-weight infants in rural Ghana: a population-based, prospective cohort study.Risk of adverse birth outcomes in populations living near landfill sitesThe use of randomisation-based efficacy estimators in non-inferiority trials.Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trial.Human Papillomavirus DNA Methylation Predicts Response to Treatment Using Cidofovir and Imiquimod in Vulval Intraepithelial Neoplasia 3.Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial.Effect of early neonatal vitamin A supplementation on mortality during infancy in Ghana (Neovita): a randomised, double-blind, placebo-controlled trial.Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial.Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVitA): a cluster-randomised, placebo-controlled trial.Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case.Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer.Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1.The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation.The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment.LISA: A Clinical Information and Decision Support System for Childhood Acute Lymphoblastic Leukaemia.Aetiology of stillbirths and neonatal deaths in rural Ghana: implications for health programming in developing countries.Diagnostic accuracy of verbal autopsies in ascertaining the causes of stillbirths and neonatal deaths in rural Ghana.ELCID: early lung cancer identification and diagnosis - an embedded interview study to explore patient participation and recruitment.Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer.Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial.Response to: Neoadjuvant chemoradiotherapy for oesophageal cancer: Still looking for a challenger to the CROSS regimen.A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS220 A feasibility randomised controlled trial looking at the effect on lung cancer diagnosis of giving a chest X-ray to smokers aged over 60 with new chest symptoms – the ELCID trialNEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine (OXCAP) or carboplatin/paclitaxel (CarPac) based chemoradiation (CRT) as pre-operative regimen for resectable oesophageal adenocarcinoma
P50
Q34464910-AF5F185D-E29A-4924-97ED-CDAC0030D074Q34469769-4D2AD6C2-CE58-42A9-B3F3-C952B3712CB9Q35756867-EF7C5DD2-AAB1-4676-8E0A-6F5ED33AC2B9Q35899485-30D54AFE-E5BA-4CF3-8A5E-1C658E8AED8DQ36089977-7023537F-01C4-47D4-BAB4-1B7436A6D8C2Q36232222-EC6CA0A0-6775-4C4A-99F2-CD694BDD6FDAQ36287102-57A5E147-AC96-47BE-9BFC-C41DDBCC3186Q36509392-6804DA6E-E7AC-4236-9F71-05E698BB155FQ36553353-EDBAED81-3628-4CAF-9E70-922925D5C78EQ36612531-CC13BC5F-CE74-47E2-AF64-BE817BD3AA7FQ36644501-AB06A760-85EB-4BC8-B4F2-13CCAA4254EAQ36751555-7440187C-9432-45E6-A6B2-B8AE7C541EBDQ36818873-1AB7C89A-812F-49BD-91E7-B002BCEC4B2AQ36959974-B10771EF-75EA-427E-953F-9DD8151A7A7DQ37084787-33579B59-2648-4320-A346-F26894B0FADEQ37690065-91D9ABEF-A59B-449E-A6CD-8073403BBBF5Q38578333-40B00F9E-90CA-43BA-9FC1-66310115070DQ38733008-B9E2AF17-D4AB-4C61-8348-97BA48D6CF53Q38757690-8F695093-57F7-4501-B684-7F7CAF970330Q38920673-46ED51A1-C191-46FF-99FF-6500307564B3Q38982349-79BAC4CD-B330-4A7D-B4A1-885A9B2E9798Q39029171-9FEEF328-B2BF-45C1-B136-85B366419FECQ39115244-D97F0DAC-2D7D-4D6C-835A-636E7C1A8E81Q39138977-4769E2D4-A49C-4CB9-8B47-1912332A56F6Q39571873-2A37C9A9-D2F5-4CEB-897D-14580082A494Q41055466-569C6CD7-59DE-4F51-8911-0606583C05CCQ42029319-92B38CEB-1DC9-4971-A7E8-3FD1944A6861Q42628995-C09B70A4-ABC8-4868-A8BB-5A7DF67130A2Q42674196-38625D37-6C37-4F15-ADFE-8CE7F8736514Q43246686-5E5A1C0F-FB52-4C52-8889-66A4EBA2D4D4Q45788164-BA18CDE4-E8B1-47BD-9FC0-9B999FACF41EQ45825629-037164D5-6929-426C-A09D-B39249B3EFABQ46335638-C7D80D73-3971-4C14-BDBD-9C2DE7F644CFQ46407325-47E0D170-2091-4D80-AF98-EDB387942FF4Q47142302-41F1CE9B-4336-4D72-9AD6-8E8FA40D78AAQ51107636-CAC0C580-C918-4ED5-909A-EC5BCD096983Q53102011-4D62D894-DBDB-4595-96F2-21E5C18FB32FQ56528295-01F49BAA-2A2F-4CFF-AEAD-4D35DA687584Q57943944-FD43A708-66C5-4F2E-B72D-31AF4AA836ABQ59089327-3026D76E-57DF-4409-AA30-4D2942464E47
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chris Hurt
@ast
Chris Hurt
@en
Chris Hurt
@es
Chris Hurt
@nl
Chris Hurt
@sl
type
label
Chris Hurt
@ast
Chris Hurt
@en
Chris Hurt
@es
Chris Hurt
@nl
Chris Hurt
@sl
prefLabel
Chris Hurt
@ast
Chris Hurt
@en
Chris Hurt
@es
Chris Hurt
@nl
Chris Hurt
@sl
P106
P21
P31
P496
0000-0003-1206-8355
P569
2000-01-01T00:00:00Z